445 related articles for article (PubMed ID: 16831902)
21. Bone morphogenetic proteins: an update on basic biology and clinical relevance.
Schmitt JM; Hwang K; Winn SR; Hollinger JO
J Orthop Res; 1999 Mar; 17(2):269-78. PubMed ID: 10221845
[TBL] [Abstract][Full Text] [Related]
22. The bone morphogenetic proteins antagonist Noggin inhibits membranous ossification.
Aspenberg P; Jeppsson C; Economides AN
J Bone Miner Res; 2001 Mar; 16(3):497-500. PubMed ID: 11277267
[TBL] [Abstract][Full Text] [Related]
23. Bone morphogenetic proteins, their antagonists, and the skeleton.
Canalis E; Economides AN; Gazzerro E
Endocr Rev; 2003 Apr; 24(2):218-35. PubMed ID: 12700180
[TBL] [Abstract][Full Text] [Related]
24. Localization of STRO-1, BMP-2/-3/-7, BMP receptors and phosphorylated Smad-1 during the formation of mouse periodontium.
Kémoun P; Laurencin-Dalicieux S; Rue J; Vaysse F; Roméas A; Arzate H; Conte-Auriol F; Farges JC; Salles JP; Brunel G
Tissue Cell; 2007 Aug; 39(4):257-66. PubMed ID: 17662325
[TBL] [Abstract][Full Text] [Related]
25. The role of bone morphogenetic proteins in endochondral bone formation.
Tsumaki N; Yoshikawa H
Cytokine Growth Factor Rev; 2005 Jun; 16(3):279-85. PubMed ID: 15869898
[TBL] [Abstract][Full Text] [Related]
26. Bone morphogenic protein antagonists are coexpressed with bone morphogenic protein 4 in endothelial cells exposed to unstable flow in vitro in mouse aortas and in human coronary arteries: role of bone morphogenic protein antagonists in inflammation and atherosclerosis.
Chang K; Weiss D; Suo J; Vega JD; Giddens D; Taylor WR; Jo H
Circulation; 2007 Sep; 116(11):1258-66. PubMed ID: 17785623
[TBL] [Abstract][Full Text] [Related]
27. Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function.
Gazzerro E; Deregowski V; Stadmeyer L; Gale NW; Economides AN; Canalis E
Bone; 2006 Dec; 39(6):1252-60. PubMed ID: 16934545
[TBL] [Abstract][Full Text] [Related]
28. Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer.
Haudenschild DR; Palmer SM; Moseley TA; You Z; Reddi AH
Cancer Res; 2004 Nov; 64(22):8276-84. PubMed ID: 15548695
[TBL] [Abstract][Full Text] [Related]
29. BMP signaling and skeletogenesis.
Li X; Cao X
Ann N Y Acad Sci; 2006 Apr; 1068():26-40. PubMed ID: 16831903
[TBL] [Abstract][Full Text] [Related]
30. Co-expression of BMPs and BMP-inhibitors in human fractures and non-unions.
Kloen P; Lauzier D; Hamdy RC
Bone; 2012 Jul; 51(1):59-68. PubMed ID: 22521262
[TBL] [Abstract][Full Text] [Related]
31. The expression and crucial roles of BMP signaling in development of smooth muscle progenitor cells in the mouse embryonic gut.
Torihashi S; Hattori T; Hasegawa H; Kurahashi M; Ogaeri T; Fujimoto T
Differentiation; 2009 Mar; 77(3):277-89. PubMed ID: 19272526
[TBL] [Abstract][Full Text] [Related]
32. Bone morphogenetic proteins in the early development of zebrafish.
Kondo M
FEBS J; 2007 Jun; 274(12):2960-7. PubMed ID: 17521339
[TBL] [Abstract][Full Text] [Related]
33. Bmp modulators in kidney disease.
Nakamura J; Yanagita M
Discov Med; 2012 Jan; 13(68):57-63. PubMed ID: 22284784
[TBL] [Abstract][Full Text] [Related]
34. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.
Ye L; Lewis-Russell JM; Kynaston H; Jiang WG
J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136
[TBL] [Abstract][Full Text] [Related]
35. BMP modulators regulate the function of BMP during body patterning and disease progression.
Yanagita M
Biofactors; 2009; 35(2):113-9. PubMed ID: 19449438
[TBL] [Abstract][Full Text] [Related]
36. Consequences of knocking out BMP signaling in the mouse.
Zhao GQ
Genesis; 2003 Jan; 35(1):43-56. PubMed ID: 12481298
[TBL] [Abstract][Full Text] [Related]
37. [Role of BMPs and Smads during endochondral bone formation].
Tsumaki N; Horiki M; Murai J; Yoshikawa H
Clin Calcium; 2004 Jul; 14(7):52-7. PubMed ID: 15577076
[TBL] [Abstract][Full Text] [Related]
38. Ectodysplasin has a dual role in ectodermal organogenesis: inhibition of Bmp activity and induction of Shh expression.
Pummila M; Fliniaux I; Jaatinen R; James MJ; Laurikkala J; Schneider P; Thesleff I; Mikkola ML
Development; 2007 Jan; 134(1):117-25. PubMed ID: 17164417
[TBL] [Abstract][Full Text] [Related]
39. Antagonists of bone morphogenetic proteins in kidney disease.
Yanagita M
Curr Opin Investig Drugs; 2010 Mar; 11(3):315-22. PubMed ID: 20178045
[TBL] [Abstract][Full Text] [Related]
40. Ligand- and stage-dependent divergent functions of BMP signaling in the differentiation of embryonic skeletogenic progenitors in vitro.
Lorda-Diez CI; Montero JA; Choe S; Garcia-Porrero JA; Hurle JM
J Bone Miner Res; 2014 Mar; 29(3):735-48. PubMed ID: 24038612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
